Loading...
Market
What will be the public perception of CVS Caremark by end of 2024?
2
Resolution / Starting Odds
Trust significantly improves • 25%
Trust slightly improves • 25%
Trust remains the same • 25%
Trust declines • 25%
Public opinion polls, surveys, or market research reports
Story
CVS Caremark Quietly Agrees to Pay $45 Million to Settle Illinois Drug Rebate Allegations Over Four-Year Period
Jul 23, 2024, 11:18 PM
CVS Caremark has quietly agreed to pay $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to consumers over a recent four-year period. The settlement addresses claims that CVS's pharmacy benefit manager (PBM) inappropriately pocketed drug rebates through a subsidiary known as Zinc, a 'rebate aggregator,' according to a document obtained by STAT.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Outperforms Walgreens • 25%
Underperforms Walgreens • 25%
Outperforms Cigna • 25%
Underperforms Cigna • 25%
More negative • 25%
Unchanged • 25%
More positive • 25%
Mixed opinions • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Healthcare Services Expansion • 25%
Retail Innovation • 25%
Digital Transformation • 25%
Other • 25%
Improved • 25%
Worsened • 25%
No change • 25%
Mixed opinions • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Higher • 25%
Lower • 25%
Unchanged (+/- 5%) • 25%
Other • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%